Status:

UNKNOWN

Assessment of Left Atrial Mechanical Function With a True 3D Ultrasouns Arry and Comparison With the Transthoracic and Transesophageal Echocardiography

Lead Sponsor:

Klinik Hirslanden, Zurich

Conditions:

Comparison of 3D Monitored Changes of Left Atrial Volume Before and After Ablation With Conventional Transesophageal Echocardiography

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Chronic atrial fibrillation is a challenging arrhythmia requiring additional radiofrequency ablation besides pulmonary vein isolation. Atrial contractility in these patients is often impaired. Until n...

Detailed Description

Comparison of true 3D atrial volume changes to TEE and TTE findings as well as atrial pressure curves during left heart catheterization. Changing from atrial fibrillation to sinus rhythm causes change...

Eligibility Criteria

Inclusion

  • Patients undergoing electrophysiological study with the AcQmap System
  • Age ≥18 years and signed informed consent
  • German speaking

Exclusion

  • Mechanical mitral valve
  • Contraindication for left atrial ablation procedure such as: Intra-cardiac clot,
  • Pregnancy

Key Trial Info

Start Date :

November 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2019

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03331029

Start Date

November 1 2017

End Date

December 31 2019

Last Update

October 8 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Klinik Im Park

Zurich, Switzerland, 8027